Xilio Therapeutics (XLO) Receivables - Net (2024)
Xilio Therapeutics (XLO) has disclosed Receivables - Net for 1 consecutive years, with $30.0 million as the latest value for Q1 2024.
Xilio Therapeutics (XLO) has disclosed Receivables - Net for 1 consecutive years, with $30.0 million as the latest value for Q1 2024.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month